A new study in mice has identified FXR1, a protein in the same family as the one implicated in Fragile X syndrome, as a potential target for creating a new type of blood pressure-lowering medicine, according to preliminary ...
May 12, 2022
0
18
Patients with atherosclerosis today usually receive preventive treatment only after a heart attack or stroke because diagnostic methods that can identify individuals and atherosclerotic plaques with high-risk are lacking. ...
Apr 23, 2021
0
0
Blood clots in the veins—particularly those that break off and travel to the lungs—can be fatal and have become increasingly so. Yet many adults know little about their risks or the growing evidence that healthy habits ...
Oct 13, 2020
0
3
A study led by clinician scientists at RCSI University of Medicine and Health Sciences has found that Irish patients admitted to hospital with severe COVID-19 infection are experiencing abnormal blood clotting that contributes ...
Apr 30, 2020
0
5
E-cigarette use takes a serious toll on heart health—a big concern given the high prevalence of e-cigarettes and perception of e-cigarettes as a healthier alternative to traditional cigarettes, according to new research ...
Nov 11, 2019
0
6
The invention of interactive map applications has revolutionized wayfinding, providing an unprecedented level of information far beyond what printed road maps can offer. Researchers at Children's Hospital Los Angeles are ...
Oct 18, 2019
0
1
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.
Apr 24, 2019
0
16
A combination of over-the-counter antioxidants shows promise for mitigating some damaging effects of heart failure with preserved ejection fraction (HFpEF), a new study reports. The research, which will be presented today ...
Apr 9, 2019
0
6
Dementia is one of the leading causes of death in Australia, but University of Queensland research has found the disease affects men and women differently.
Mar 4, 2019
0
7
A scientist at the University of Virginia School of Medicine, working with local biotech company HemoShear Therapeutics, has created a physical, three-dimensional model of a cancer tumor that can replicate the complex nature ...
May 7, 2018
0
3
